WEBINAR & IN-PERSON EVENT
Presented by ATSE & UUSC Luncheon Series
Open to all ATSE Fellows & Guests
Date: 30 March 2022
12.00 noon AEDT for lunch
12.30pm AEDT for Zoom
Professor Laura Poole-Warren AM FTSE — Deputy Director, Tyree Foundation Institute of Health Engineering
Professor Nigel Lovell FTSE — Head of the Graduate School of Biomedical Engineering, UNSW & Director, Tyree Foundation Institute of Health Engineering
Dr Sze-Yuan Ooi — Director of Coronary Care Unit, Prince of Wales Hospital
You are invited to attend the next ATSE & UUSC luncheon series presentation on 30 March 2022, to hear of the remarkable developments in implanted and/or wearable sensors operating in a fully integrated digital ecosystem which will provide continuity of care from the hospital, to the community, to the home, saving lives at the same time saving money.
We live in a world where technology is increasingly assisting healthcare workers to remotely monitor and manage health. We can monitor our own wellness via fitness trackers, smart watches and mobile phone technology; the future of monitoring and managing health and wellness – Connected Health – lies in developing intelligent systems that address clinical and patient needs by connecting software, hardware, medical technologies and data analytics to provide unparalleled integration of health data to develop the best solution tailored for the individual person and do so in real time. It is critical that these Connected Health approaches align with existing clinical workflows.
Leading medical researchers and ATSE Fellows, Professor Laura Poole-Warren and Professor Nigel Lovell will be joined by Dr Sze-Yuan Ooi to present two remarkable developments in Connected Health. The recently established Tyree Institute of Health Engineering (IHealthE) at Prince of Wales Hospital and School of Biomedical Engineering (UNSW) aims to be a global leader in transforming health care practice and delivery by developing innovative, transformational, and cost-effective health technologies to meet patient and clinician needs.
World first developments by IHealthE, including a patient-centred, remote monitoring smartphone application system (TCC) already in trials links community-based patients with hospital specialists, enabling management of patients with coronary disease, heart failure and stroke in the community, with further development of TCC to manage chronic obstructive pulmonary disease, mental health, and gestational diabetes.
Open to all Fellows and their guests. Fellows are encouraged to circulate the event information to any guests* they would like to attend.
To attend the event please register early to avoid disappointment as the venue has limited capacity.
*Guests must indicate during registration the Fellow they are a guest of.
Professor Laura Poole-Warren AM FTSE
Deputy Director, Tyree Foundation Institute of Health Engineering
Laura Poole-Warren is currently a Professor in the Graduate School of Biomedical Engineering, UNSW Sydney where she leads a research group focussed on design and development of novel neural interfacing materials for neural stimulation and recording electrodes. Laura held several senior leadership roles at UNSW over the past 15 years, most recently was Pro Vice-Chancellor and Dean of Graduate Research in the Division of Research from 2010 to 2018. She has held appointments as a preclinical scientist in the biomedical industry working on development of implantable devices including wound dressings and embolic agents for cancer treatment.
She also has expertise in regulatory requirements for medical technology having served for 10 years as a member of the Australian Commonwealth Government statutory Advisory Committee on Medical Devices (ACMD) advising the Therapeutic Goods Administration on the safety of medical devices. Laura was awarded honours in 2020 as a member of the Order of Australia (AM) for service to Biomedical Engineering and Education and is an elected Fellow of three academies, ATSE, AIMBE and IUSBSE. She is also an Associate Editor of the leading journal in her field, Biomaterials, and sits on the editorial board of the Journal of Neural Engineering.
Scientia Professor Nigel Lovell FTSE
Head of the Graduate School of Biomedical Engineering, UNSW & Director, Tyree Foundation Institute of Health Engineering
Nigel Lovell received his BE (Hons) and PhD degrees from UNSW Sydney, Australia. He is currently at the Graduate School of Biomedical Engineering UNSW Sydney where he holds a position of Scientia Professor and Head of School. He has authored 300+ journal papers and been awarded over $97 million in R&D and infrastructure funding. Over his career he has mentored 70 PhD students and delivered more than a hundred keynote presentations. He is a Fellow of seven learned academies throughout the world including ATSE, IEEE and AIMBE.
His research work has covered areas of expertise ranging from cardiac and retinal modeling, medical informatics and data analytics especially related to telehealth technologies, biological signal processing, and visual prosthesis design. For 2017 and 2018 he was the President of the world’s largest biomedical engineering society – the IEEE Engineering in Medicine and Biology Society.
Dr Sze-Yuan Ooi
Director of Coronary Care Unit, Prince of Wales Hospital
Sze-Yuan Ooi is a clinician researcher with extensive clinical experience and expertise in the fields of coronary intervention and cardiac device implantation, including novel implantable cardiac devices and remote monitoring technologies. He is a Senior Staff Specialist at the Prince of Wales Hospital and is the current Director of the Coronary Care Unit.
Sze-Yuan holds a Conjoint Senior Lecturer position with UNSW and was recently appointed as the Clinical Lead for the Connected Health research program, in the Institute of Health Engineering, UNSW. His research interests include the role of inflammation in the pathogenesis of coronary atherosclerosis, coronary physiology, novel assessments of and modulation of the coronary microcirculation, new device technology and mHealth.
Sze-Yuan has co-designed and validated a smartphone application-based model of care, called TeleClinical Care (TCC). TCC has been implemented to facilitate large-scale monitoring of both patients with COVID-19 and cardiovascular patients without COVID-19 in the community. It lies at the core of the South East Sydney Local Health District strategy to establish remote monitoring as a means for providing a continuum of care for chronic disease in the post-COVID era.